+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Deoxycholic acid

SBP03885
83-44-3
98%
普瑞法
Deoxycholic acid is a strong promoter of hepatocarcinogenesis with possible complete carcinogenicity in the liver and promotion potential for tumor development in the small intestine. Loss of deoxycholic acid-induced EGFR/Ras/MAPK pathway function potentiates deoxycholic acid-stimulated FAS-induced hepatocyte cell death via a reduction in the expression of c-FLIP isoforms. Deoxycholic acid is a bile acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 12 respectively. It has a role as a human blood serum metabolite. It is a C24-steroid, a dihydroxy-5beta-cholanic acid and a bile acid. It is a conjugate acid of a deoxycholate.
Catalog No Package Original Price Price Inventory Quantity Operating
SBP03885-100mg 100mg
SBP03885-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

PRKCA NR1H4 GPBAR1 PPARG NFKB1 CASP3 CYP7A1
NR1H4 GPBAR1 PPARG NFKB1 FXR
ABCG5 FXR TGR5 SLC10A2 ABCB11
NR1H4 GPBAR1 SLC10A1 CYP7A1 ABCB11

Deoxycholic acid Related Products

Product drug property prediction parameters

  • 77.7600

  • 3.9524

  • 1.7580

  • .0435

  • 4.2188

  • 6.0849

  • Low

  • 90.0381

  • 4.3653

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • No